title: Is the dose of thioguanine the key to better safety profile?
authors.affiliation: Inserm U954 and Department of Gastroenterology and Hepatology, Henri Poincaré 1 University, Nancy University Hospital, Vandœuvre-lès-Nancy, France.
authors.forename: Jean-Baptiste
authors.initials: JB
authors.lastname: Chevaux
authors.forename: Laurent
authors.initials: L
authors.lastname: Peyrin-Biroulet
mesh_terms: D003093:Colitis, Ulcerative / Q000188:drug therapy; D003424:Crohn Disease / Q000188:drug therapy; D019317:Evidence-Based Medicine; D005765:Gastrointestinal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008103:Liver Cirrhosis / Q000139:chemically induced; D013866:Thioguanine / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D005765:Gastrointestinal Agents; D013866:Thioguanine